Literature DB >> 26159354

The Infectious and Noninfectious Dermatological Consequences of Flooding: A Field Manual for the Responding Provider.

Justin P Bandino1,2, Anna Hang3, Scott A Norton4.   

Abstract

Meteorological data show that disastrous floods are increasingly frequent and more severe in recent years, perhaps due to climatic changes such as global warming. During and after a flood disaster, traumatic injuries, communicable diseases, chemical exposures, malnutrition, decreased access to care, and even mental health disorders dramatically increase, and many of these have dermatological manifestations. Numerous case reports document typical and atypical cutaneous infections, percutaneous trauma, immersion injuries, noninfectious contact exposures, exposure to wildlife, and exacerbation of underlying skin diseases after such disasters as the 2004 Asian tsunami, Hurricane Katrina in 2005, and the 2010 Pakistan floods. This review attempts to provide a basic field manual of sorts to providers who are engaged in care after a flooding event, with particular focus on the infectious consequences. Bacterial pathogens such as Staphylococcus and Streptococcus are still common causes of skin infections after floods, with atypical bacteria also greatly increased. Vibrio vulnificus is classically associated with exposure to saltwater or brackish water. It may present as necrotizing fasciitis with hemorrhagic bullae, and treatment consists of doxycycline or a quinolone, plus a third-generation cephalosporin and surgical debridement. Atypical mycobacterial infections typically produce indolent cutaneous infections, possibly showing sporotrichoid spread. A unique nontuberculous infection called spam has recently been identified in Satowan Pacific Islanders; combination antibiotic therapy is recommended. Aeromonas infection is typically associated with freshwater exposure and, like Vibrio infections, immunocompromised or cirrhotic patients are at highest risk for severe disease, such as necrotizing fasciitis and sepsis. Various antibiotics can be used to treat Aeromonas infections. Melioidosis is seen mainly in Southeast Asia and Australia, particularly in rice farmers, and can remain latent for many years before presenting as the host's immunocompetence wanes. It can present with a variety of skin findings or as a nonspecific febrile illness, and preferred treatment consists of ceftazidime or a carbapenem with trimethoprim/sulfamethoxazole (TMP/SMX) for 2 weeks, then continuing TMP/SMX for at least 3 months. Leptospirosis is a waterborne zoonosis that is often prevalent after heavy rains or flooding. Different forms exist, including Fort Bragg fever, which produces a distinctive erythematous papular rash on the shins. Doxycycline is often sufficient; however, volume and potassium repletion may be necessary if renal involvement exists. Chromobacterium violaceum infection may occur after open skin is exposed to stagnant or muddy water. Cultured colonies produce a unique violacein pigment, and treatment typically consists of a carbapenem. Both typical and atypical fungal infections are increased in the flooding disaster scenario, such as dermatophytosis, chromoblastomycosis, blastomycosis, and mucormycosis. Appropriate antifungals should be used. In addition, land inundated with water expands the habitat for parasites and/or vectors, thus increased vigilance for regional parasitic infections is necessary after a flood. Lastly, noninfectious consequences of a flooding disaster are also common and include miliaria, immersion foot syndromes, irritant and allergic contact dermatitis, traumatic wounds and animal bites, and arthropod assault, as well as exacerbation of existing skin conditions such as atopic dermatitis, psoriasis, and alopecia areata due to increased stress or nonavailability of daily medications.

Entities:  

Mesh:

Year:  2015        PMID: 26159354     DOI: 10.1007/s40257-015-0138-4

Source DB:  PubMed          Journal:  Am J Clin Dermatol        ISSN: 1175-0561            Impact factor:   7.403


  8 in total

Review 1.  Chromoblastomycosis.

Authors:  Flavio Queiroz-Telles; Sybren de Hoog; Daniel Wagner C L Santos; Claudio Guedes Salgado; Vania Aparecida Vicente; Alexandro Bonifaz; Emmanuel Roilides; Liyan Xi; Conceição de Maria Pedrozo E Silva Azevedo; Moises Batista da Silva; Zoe Dorothea Pana; Arnaldo Lopes Colombo; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

Review 2.  Climate Change and Inpatient Dermatology.

Authors:  R Fathy; Misha Rosenbach
Journal:  Curr Dermatol Rep       Date:  2020-08-22

Review 3.  Relationship of environmental disturbances and the infectious potential of fungi.

Authors:  Hazael Hernandez; Luis R Martinez
Journal:  Microbiology       Date:  2018-02-05       Impact factor: 2.777

Review 4.  Infectious Diseases After Hydrologic Disasters.

Authors:  Stephen Y Liang; Nicole Messenger
Journal:  Emerg Med Clin North Am       Date:  2018-09-06       Impact factor: 2.264

Review 5.  Climate change and pediatric skin health.

Authors:  April Schachtel; Jonathan A Dyer; Markus D Boos
Journal:  Int J Womens Dermatol       Date:  2020-07-24

6.  Emergency Medical Teams' Responses during the West Japan Heavy Rain 2018: J-SPEED Data Analysis.

Authors:  Odgerel Chimed-Ochir; Yui Yumiya; Akihiro Taji; Eisaku Kishita; Hisayoshi Kondo; Akinori Wakai; Kouki Akahoshi; Kayoko Chishima; Yoshiki Toyokuni; Yuichi Koido; Tatsuhiko Kubo
Journal:  Prehosp Disaster Med       Date:  2022-02-28       Impact factor: 2.040

Review 7.  Infectious Diseases Associated with Hydrometeorological Hazards in Europe: Disaster Risk Reduction in the Context of the Climate Crisis and the Ongoing COVID-19 Pandemic.

Authors:  Maria Mavrouli; Spyridon Mavroulis; Efthymios Lekkas; Athanassios Tsakris
Journal:  Int J Environ Res Public Health       Date:  2022-08-17       Impact factor: 4.614

Review 8.  The effects of climate change on infectious diseases with cutaneous manifestations.

Authors:  Sarah J Coates; Scott A Norton
Journal:  Int J Womens Dermatol       Date:  2020-07-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.